Norwegian government to double the number of clinical studies.
Author Archive for: oslocancer
This author has yet to write their bio.Meanwhile lets just say that we are proud oslocancer contributed a whooping 486 entries.
Entries by oslocancer
Dehns acquires Norwegian Intellectual Property consultancy Leogriff.
Ultimovacs has announced a new clinical study targeted at patients with ovarian cancer.
CONNECT is a completely new public-private collaboration in cancer precision medicine.
Read a selection of our news from 2020.
Read the top news from 2020 from a few of our members.
Update from Targovax on melanoma study shows responses in 7 of 20 patients.
BerGenBio is testing the company’s cancer medicine as a treatment for Covid-19.
Radforsk funding call for photodynamic therapy and photochemical internalization (PDT/PCI) related research.
The road to becoming a researcher can take many surprising routes.
Contact us >
Oslo Cancer Cluster Innovation Park opened in May 2015.
The Innovation Park brings together the oncology-value chain from basic research to industry within the Oslo-area.
Our vision is to create Europe's leading environment for education, research and industry within oncology, shortening the development time of new cancer treatments.